On Wednesday, 28 October, company briefings by Meiwa Corporation and Tsubota Laboratory were held in Sapporo, along with an equity investment seminar by mom investor Choruko (ちょる子). The event was held at the 4th-floor hall of Hokkaido Jichiro Hall and also featured exhibition booths.
At the briefing hosted by Japan Securities Newspaper, representatives explained the business operations and growth strategies of Meiwa Corporation and Tsubota Laboratory, and the initiatives of both companies were presented in a dialogue format. Meiwa Corporation explained its diverse business operations centred on chemicals, as well as its shareholder return policy and outlook. Tsubota Laboratory presented the development status of pharmaceuticals and medical devices in the ophthalmic disease field, along with its revenue model for multiple out-licensed products.
In the third part, an equity investment seminar was held, at which mom investor Choruko (ちょる子) discussed her market outlook and investment strategy for 2026 from a practical perspective. Topics included how to assess the macroeconomic environment, positioning strategies for individual investors and the mindset needed during market downturns. She also shared her experience of building ¥500 million from ¥2.4 million.